Modification of tumor cells by a low dose of Newcastle Disease Virus (original) (raw)

1988, European Journal of Immunology

Viral modification increases the frequency of tumor-specific CTL * This work was supported by a grant from the DFG (Schi 4614-2) and by the Wilhelm Sander Stiftung. Correspondence: Volker Schirrmacher, Deutsches Krebsforschungszentrum, Institut f i r Immunologie und Genetik, Im Neuenheimer Feld 280, D-6900 Heidelberg, FRG Abbreviations: CTL: Cytotoxic T lymphocytes pCTL: Precursor CTL HU. Hemagglutination units IL 2: Interleukin 2 LDA: Limiting dilution analysis LU: Lytic units MLC: Mixed leukocyte culture MLTC: Mixed leukocyte tumor cell culture NDV: Newcastle Disease Virus TATA: Tumor-associated transplantation antigen IL2 Interleukin 2 lo, 2": Primary and secondary immunization 0 VCH Verlagsgesellschaft mbH, D-6940 W&nheim, 1988

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact